28 April 2026 in British Journal of Haematology
Summary: ETV6‐related thrombocytopenia (ETV6‐RT) is an inherited platelet disorder caused by germline ETV6 variants. Despite recent progress, the mechanisms underlying platelet dysfunction in ETV6‐RT remain unclear. We investigated 12 patients from six families using functional assays, electron microscopy, quantitative proteomics and cytoskeletal imaging. Most patients exhibited mild‐to‐moderate thrombocytopenia with variable paediatric bleeding symptoms (median International Society on Thrombosis and Haemostasis Bleeding Assessment Tool 3, range 1–9) but consistently mild bleeding in adulthood (median 0, range 0–1). Ex vivo thrombus formation was reduced independent of platelet count. Electron microscopy revealed defective platelet shape maintenance, characterized by spheroid morphology, reduced D max / D min ratios and diminished alpha‐granule pools. Flow cytometry and single‐platelet total internal reflection fluorescence imaging demonstrated largely preserved calcium signalling but impaired activation‐dependent shape change, dense‐granule release and integrin activation. Proteomics showed reduced alpha‐granule and lysosomal proteins alongside imbalanced regulators of actin remodelling and β‐tubulin. Phalloidin staining confirmed impaired actin cytoskeletal remodelling with reduced lamellipodia formation, while immunofluorescence revealed abnormal β1‐tubulin localization with disrupted marginal bands and reduced lysosome‐associated membrane protein 1 (LAMP1) expression. Additionally, granulocyte recruitment and migration within thrombi were impaired, suggesting broader thromboinflammatory defects. These findings suggest that combined disruption of cytoskeletal integrity and granule biogenesis underlies impaired thrombus formation in ETV6‐RT, providing mechanistic insight into the haemostatic defects associated with this disorder.
8 July 2024 in Pediatric Hematology/Oncology and Immunopathology
The formation of extracellular DNA traps by neutrophils, or NETs (neutrophil extracellular traps) plays an essential role in many pathological processes related to hematological, oncological, and immunological diseases. This mechanism of the programmed cell death of neutrophils and other leukocytes appears to be also involved in the pathogenesis of thrombosis and thrombotic complications of a variety of disorders. In this review, we discuss the pathways of intracellular signaling leading to neutrophil activation in thrombosis and hemostasis. Even though the biochemical reactions in a cell are quite well investigated, the regulation of activity of specific proteins involved in NETosis, such as NADPH oxidase (NOX) and protein-arginine deiminase (PAD4), requires further investigation. Current approaches to the pharmacological modulation of NETosis are also specifically addressed here.
31 May 2025 in Medical academic journal
ЛЕЛуговцов Андрей Егорович
+3
BACKGROUND: Cardiovascular diseases are the leading cause of mortality worldwide. Chronic heart failure is accompanied by hemodynamic disturbances, including alterations in blood microrheological properties. Changes in erythrocyte deformability may lead to impaired activation and interaction of platelets and neutrophils, contributing to thrombosis and the progression of chronic heart failure. AIM: Determination of neutrophil activity and thrombus formation in an ex vivo model of thromboinflammation in patients with chronic heart failure with simultaneous assessment of blood microrheology. METHODS: The study involved 21 patients with a diagnosis of chronic heart failure and 8 healthy volunteers. The patients and volunteers underwent determination of the biochemical composition of blood plasma and assessment of the condition of the blood elements. The thromboinflammation was evaluated in whole heparinized blood using parallel-flat flow chambers coated with type I collagen at a shear rate of 100 1/s. The deformability parameters of erythrocytes were measured in vitro using the method of laser diffractometry. Erythrocyte aggregation was determined by diffuse light scattering from whole blood samples. RESULTS: For thrombus areas, no statistical differences were found between healthy controls and patients with chronic heart failure. However, the neutrophil velocities for patients with chronic heart failure were significantly lower than for healthy controls (0.11 ± 0.02 µm/s for chronic heart failure versus 0.16 ± 0.04 µm/s for healthy controls). The thrombus areas for patients with chronic heart failure at 5 and 10 minutes of growth correlated with the concentration of red blood cells and the average volume of red blood cells. Also, the aggregation coefficients of erythrocytes A1 and A2 characterizing the intensity of the process of formation of linear and three-dimensional aggregates positively correlated with thrombus area. In addition, mean corpuscular volume, erythrocyte deformability indices, and yield strength of the erythrocytes correlated with neutrophil movement velocities. CONCLUSION: Thus, although there is no significant change in thrombus formation in chronic heart failure, however, we can talk about a decrease in neutrophil activity, possibly associated with the increase in blood viscosity.
24 June 2025 in Medical academic journal
BACKGROUND: Neutrophils are essential in tumor growth, and their functional state can serve as a prognostic biomarker. However, the functional characteristics of peripheral blood neutrophils, such as chemotaxis and predisposition to NETosis, in female patients with luminal breast cancer have not been sufficiently explored. Studying these parameters may provide new insights into the mechanisms of disease progression and response to therapy. AIM: This work aimed to analyze the chemotactic activity of neutrophils and predisposition to NETosis in blood samples of female patients with locally advanced luminal breast cancer undergoing treatment (neoadjuvant chemotherapy) at the Loginov Moscow Clinical Scientific Center. METHODS: The study was conducted on blood samples from six patients with stage 3 luminal B, HER2-negative breast cancer before and 2 months after the start of antitumor therapy. Blood samples from healthy adult volunteers were used as controls. The work was performed using fluorescence microscopy methods for neutrophil chemotaxis with the growth of blood clots and the number of extracellular DNA traps of neutrophils by reaction with Hoechst 33342 and antibodies against myeloperoxidase and neutrophil elastase in smears of blood plasma rich in leukocytes. RESULTS: Before the start of neoadjuvant therapy, the level of NETosis is significantly increased (30% ± 14% versus 4.6% ± 3.4% in healthy donors), whereas most female patients undergoing therapy experience its reduction (17% ± 17%). The speed of neutrophil movement is increased in some female patients (0.17 ± 0.06 versus 0.113 ± 0.009 μm/s in healthy donors) and goes down during therapy (0.10 ± 0.03 μm/s). At the same time, the number of neutrophils associated with blood clots decreases during therapy (25 ± 18 versus 61 ± 23) even in patients with neutrophilia. CONCLUSION: It has been demonstrated for the first time that in female patients with luminal B, HER2-negative breast cancer, the neutrophil chemotaxis speed deviates from the standard; at the same time, their adhesion is reduced, and peripheral blood neutrophils are significantly more predisposed to NETosis than in healthy donors.